| Oct 29 |
10x Genomics falls 7% on 2024 revenue guidance cut
|
| Oct 29 |
10x Genomics, Inc. 2024 Q3 - Results - Earnings Call Presentation
|
| Oct 29 |
10x Genomics GAAP EPS of -$0.30 beats by $0.02, revenue of $151.64M in-line
|
| Oct 29 |
10x Genomics: Q3 Earnings Snapshot
|
| Oct 29 |
10x Genomics Reports Third Quarter 2024 Financial Results
|
| Oct 29 |
Zacks Industry Outlook Medical Systems, 10x Genomics and Omnicell
|
| Oct 28 |
10x Genomics Q3 2024 Earnings Preview
|
| Oct 28 |
Lower Instruments Sales to Hurt TXG Q3 Earnings, Prelim Sales Down
|
| Oct 28 |
3 Medical Info Systems Stocks to Gain From Healthcare Digitization
|
| Oct 23 |
10x Genomics (TXG) Upgraded to Strong Buy: Here's Why
|
